Disribution kinetics of cardioprotector ALM-802 in rat organs and tissues
https://doi.org/10.37489/2587-7836-2022-2-17-22
Abstract
The distribution kinetics of a compound with cardioprotective activity, N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino] ethyl}-1,2-ethanediamine (ALM-802) in rat tissues and organs after single intragastric administration at a dose of 100 mg/kg. The values of ALM-802 tissue availability were determined. Tissue availability of ALM-802 falls in a row: kidneys→liver→heart→spleen→skeletal muscle→brain (129.3; 27.2; 20.9; 15.3; 5.9 and 0.3, respectively). It was found that ALM-802 is excreted from the body rather slowly: kel values ranged from 0.0252 to 0.0885 h–1, MRT values were 7.6–59.3 h.
About the Authors
O. Yu. KravtsovaRussian Federation
Kravtsova Oxana Yu., PhD of Biological sciences, researcher scientist of pharmacokinetics laboratory. SPIN code: 1733-2330
Moscow
G. B. Kolyvanov
Russian Federation
Kolyvanov Gennadiy B., Dr. Sci. in Biology, Leading researcher of the laboratory of pharmacokinetics. SPIN code: 2538-8639
Moscow
A. A. Litvin
Russian Federation
Litvin Alexander A., Dr. Sci. in Biology, Leading researcher of the laboratory of pharmacokinetics. SPIN code: 6193-5770
Moscow
P. O. Bochkov
Russian Federation
Bochkov Pavel O., PhD in Biology, Senior Research Officer of laboratory pharmacokinetics. SPIN code: 5576-8174
Moscow
V. P. Zherdev
Russian Federation
Zherdev Vladimir P., Dr. Sci. in Medicine, professor, Head of laboratory pharmacokinetics. SPIN code: 2213-9592
Moscow
References
1. Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv. Ch.I. Moscow:Grif I K, 2013 (In Russ).
2. Kryzhanovskii SA, Likhosherstov AM, Tsorin IB, Stolyaruk VN, Vititnova MB, Mokrov GV, Gudasheva TA. Screening of the compounds having cardiotropic activity among the α, ω-diarilmetyl derivatives of bis-(ω-aminoalkyl) amines. Farmakokinetika i Farmakodinamika. 2016;(2):10–13. (In Russ).
3. Tsorin IB, Barchukov VV, Vititnova MB, Likhosherstov AM, Mokrov GV, Kryzhanovskii SA. Cardioprotective effects of compound ALM-802 on subendocardial ischemia models. Farmakokinetika i farmakodinamika. 2021;(1):18–22 (In Russ). DOI: 10.37489/2587-7836-2021-1-18-22.
4. Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Gudasheva TA, Kryzhanovskii SA. Anti-ischemic activity of triamine ALM-802 under conditions of endothelial dysfunction. Bulletin of Experimental Biology and Medicine. 2019;167(4):443–446. (In Russ).
5. Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Kryzhanovskii SA. A comparative study of the anti-ischemic activity of trimetazidine and the compound ALM-802 under conditions of endothelial dysfunction. Farmakokinetika i Farmakodinamika. 2019;(2):23–27. (In Russ). DOI: 10.24411/2587-7836-2019-10042.
6. Kolyvanov GB, Bochkov PO, Litvin AA, Shevchenko RV, Podolko AL, Zherdev VP. Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats. Farmakokinetika i farmakodinamika. 2021;(2):31–35. (In Russ). DOI: 10.37489/2587-7836-2021-2-31-35.
7. Seredenin SB, Mokrov GV, Kryzhanovskii SA, Likhosherstov AM, Stolyaruck VN et al. Bis(methoxybenzylaminoalkyl)aminy, obladayushie kardiotropnoy aktivnost`yu. Patent na izobretenie RU 2624438, 04.07.2017. Заявка № 2014105635 от 17.02.2014 (In Russ).
Review
For citations:
Kravtsova O.Yu., Kolyvanov G.B., Litvin A.A., Bochkov P.O., Zherdev V.P. Disribution kinetics of cardioprotector ALM-802 in rat organs and tissues. Pharmacokinetics and Pharmacodynamics. 2022;(2):17-22. (In Russ.) https://doi.org/10.37489/2587-7836-2022-2-17-22